These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 666373)

  • 21. Release of vasoactive intestinal polypeptide (VIP) by intraduodenal stimuli.
    Schaffalitzky de Muckadell OB; Fahrenkrug J; Holst JJ; Lauritsen KB
    Scand J Gastroenterol; 1977; 12(7):793-9. PubMed ID: 594650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hexamethonium and atropine on the basal levels of immunoreactive vasoactive intestinal polypeptide in dogs.
    Misawa T; Chijiiwa Y; Ibayashi H
    Gastroenterol Jpn; 1986 Dec; 21(6):579-83. PubMed ID: 2883064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal polypeptide (VIP) in cirrhosis: arteriovenous extraction in different vascular beds.
    Henriksen JH; Staun-Olsen P; Fahrenkrug J; Ring-Larsen H
    Scand J Gastroenterol; 1980; 15(7):787-92. PubMed ID: 7209387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive intestinal peptide in the regulation of renin secretion.
    Porter JP; Thrasher TN; Said SI; Ganong WF
    Am J Physiol; 1985 Jul; 249(1 Pt 2):F84-9. PubMed ID: 3893159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of vasoactive intestinal peptide receptors in canine liver membranes.
    Kiso T; Ito S; Ohta T; Asano T; Nakazato Y
    Biochem Pharmacol; 1994 Jan; 47(2):241-5. PubMed ID: 8304967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic clearance of somatostatin and gastrin-releasing peptide.
    Wolfe MM; Doyle JW; McGuigan JE
    Life Sci; 1987 Jan; 40(4):335-42. PubMed ID: 2880271
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Properties of vasoactive intestinal peptide-receptor interaction in rat liver membranes.
    Guerrero JM; Prieto JC; Ramírez-Cárdenas R; Calvo JR; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):1-8. PubMed ID: 6113623
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in the concentration of vasoactive intestinal peptide in intestinal lymph in response to vagal stimulation in the calf.
    Edwards AV; Birchman PM; Mitchell SJ; Bloom SR
    Experientia; 1978 Sep; 34(9):1186-7. PubMed ID: 720519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axonal transport of vasoactive intestinal peptide in sciatic nerve.
    Giachetti A; Said SI
    Nature; 1979 Oct; 281(5732):574-5. PubMed ID: 91110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of portacaval shunt, transposition, and dimethylnitrosamine-induced chronic liver injury on pancreatic hormones and amino acids in dog.
    Hashimoto N; Ishikawa Y; Utsunomiya J
    J Surg Res; 1989 Jan; 46(1):35-40. PubMed ID: 2644488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanyl nucleotide regulation of vasoactive intestinal peptide interaction with rat liver membranes.
    Ramírez-Cárdenas R; Prieto JC; Guerrero JM; Goberna R
    Rev Esp Fisiol; 1981 Mar; 37(1):9-16. PubMed ID: 6264553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoreactive vasoactive intestinal polypeptide in rat hypophysial portal blood.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1981 Feb; 108(2):395-8. PubMed ID: 7449730
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimulation by serotonin of vasoactive intestinal polypeptide release into rat hypophysial portal blood.
    Shimatsu A; Kato Y; Matsushita N; Katakami H; Yanaihara N; Imura H
    Endocrinology; 1982 Jul; 111(1):338-40. PubMed ID: 7084118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating levels of vasoactive intestinal polypeptide in liver disease.
    Hunt S; Vaamonde CA; Rattassi T; Berian G; Said SI; Papper S
    Arch Intern Med; 1979 Sep; 139(9):994-6. PubMed ID: 475538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide-associated inhibition of stimulated gastric secretion. II. Inhibition of pentagastrin-stimulated gastric secretion.
    Escourrou J; Ebeid AM; Fischer JE
    Am J Surg; 1980 Jun; 139(6):824-8. PubMed ID: 7386737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Budd-Chiari syndrome by side-to-side portacaval shunt: experimental and clinical results.
    Orloff MJ; Johansen KH
    Ann Surg; 1978 Oct; 188(4):494-512. PubMed ID: 697434
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasoactive intestinal peptide in man: pharmacokinetics, metabolic and circulatory effects.
    Domschke S; Domschke W; Bloom SR; Mitznegg P; Mitchell SJ; Lux G; Strunz U
    Gut; 1978 Nov; 19(11):1049-53. PubMed ID: 730072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS; Alfonzo M; Kowal J
    Endocrinology; 1980 Apr; 106(4):1270-5. PubMed ID: 6244149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nervous release of vasoactive intestinal polypeptide in the gastrointestinal tract of cats: possible physiological implications.
    Fahrenkrug J; Haglund U; Jodal M; Lundgren O; Olbe L; de Muckadell OB
    J Physiol; 1978 Nov; 284():291-305. PubMed ID: 215756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of vasoactive intestinal peptide on gastric secretion in the cat.
    Vagne M; Konturek SJ; Chayvialle JA
    Gastroenterology; 1982 Jul; 83(1 Pt 2):250-5. PubMed ID: 6806139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.